News
The XGBoost-based approach demonstrated robust external validation across multiple centers, supporting clinical adoption to guide personalized treatment decisions.
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study Osteosarcoma (OS) is the most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback